Nicklas Westerholm – new CEO

Apr 11, 2017

We welcome Nicklas Westerholm as the new CEO of PledPharma. Nicklas will take office on June 16.

Nicklas Westerholm, is a business leader with extensive management experience (20 years) across multiple geographies within the pharmaceutical industry. Management experience gained from a broad range of senior executive management roles globally within Research & Development, Manufacturing & Supply Chain and Finance/Investor relations, AstraZeneca.

Nicklas Westerholm has studied analytical and organic chemistry at Stockholm University, and Chemical Engineering at KTH Royal Institute of Technology. He has also participated in Post graduate programs at the University of Warwick, INSEAD and Harvard Business School.